According to Endo International 's latest financial reports the company's current EPS (TTM) is -$4.02. In 2022 the company made an earnings per share (EPS) of -$12.44 a decrease over its 2021 EPS that were of -$2.63.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.02 | -67.68% |
2022 | -$12.44 | 373% |
2021 | -$2.63 | -424.69% |
2020 | $0.81 | -143.55% |
2019 | -$1.86 | -59.57% |
2018 | -$4.60 | -49.56% |
2017 | -$9.12 | -39.29% |
2016 | -$15.02 | 115.43% |
2015 | -$6.97 | 32.58% |
2014 | -$5.26 | -11.26% |
2013 | -$5.93 | -7.4% |
2012 | -$6.40 | -498.39% |
2011 | $1.61 | -27.9% |
2010 | $2.23 | -1.91% |
2009 | $2.27 | 10.27% |
2008 | $2.06 | 21.18% |
2007 | $1.70 | 65.05% |
2006 | $1.03 | -32.24% |
2005 | $1.52 | 40.74% |
2004 | $1.08 | 107.69% |
2003 | $0.52 | 73.33% |
2002 | $0.30 | -175% |
2001 | -$0.40 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Cara Therapeutics
CARA | -$2.06 | -48.76% | ๐บ๐ธ USA |